← Back to Search

VIA Disc NP for Discogenic Pain

N/A
Recruiting
Research Sponsored by VIVEX Biologics, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1, 3, 6, 12, & 24 months
Awards & highlights

Study Summary

Registry is to observe and trend patterns of care and outcomes for patients treated with VIA Disc NP.

Eligible Conditions
  • Discogenic Pain
  • Lower Back Pain
  • Back Pain

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1, 3, 6, 12, & 24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1, 3, 6, 12, & 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Numeric Pain Rating Scale (NPRS)
Oswestry Disability Index (ODI)
Pain Medication
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: VIA Disc NPExperimental Treatment1 Intervention
Patients meeting study criteria receiving Vivex VIA Disc NP injection as treatment

Find a Location

Who is running the clinical trial?

Moxie ClinicalUNKNOWN
VIVEX Biologics, Inc.Lead Sponsor
7 Previous Clinical Trials
10,306 Total Patients Enrolled
1 Trials studying Discogenic Pain
10,000 Patients Enrolled for Discogenic Pain
Jasmine WilsonStudy Directorcro

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~333 spots leftby Jan 2027